Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

July 24, 2014

Early Warning of Any Cancer

Immunosignature analysis, a multiplexed means of profiling circulating antibodies, reveals patterns unique to specific cancers.

Early Warning of Any Cancer

Immunosignaturing could enable early cancer detection and deliver universality—a single platform could be used for any cancer. [Biodesign Institute, Arizona State University]

The reductionist approach to cancer detection—scrutinizing a particular set of biomarkers for each cancer—is fraught with obstacles It may not be possible, in many instances, to rely on just a few biomarkers, given the complexity of the body’s response to disease Worse, many biomarkers are elusive, so rare as to ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content